Explore EATRIS as a companya patienta scientista policy-makera visitor Login
Empowering Patients in the Digital Health Era: Highlights from the EATRIS-CONNECT Event
The International Drug Repurposing Conference #iDR25 Successfully Wraps Up in Amsterdam
EATRIS Services Now Featured in the European Innovation Council (EIC) Service Catalogue
New Publication Highlights EATRIS Contribution to Multi-Omics Standards in Phenomics
EATRIS Leads Strategic Mapping of ATMP Capacities Across Europe through PRECISEU
University of Coimbra Launches €5M Gene Therapy Innovation Hub to Accelerate Gene Therapy Development Across Europe
Florence Bietrix Appointed Section Editor for the Journal of Translational Medicine
EATRIS Portugal Governor Rui Santos Ivo Elected Chair of EMA’s Management Board
EATRIS Guest Edits Cell & Gene Therapy Insights Special Issue on Expanding Cellular Immunotherapy
REMEDi4ALL featured in NYT article on AI and drug repurposing
EATRIS co-signs the European Health Data Space (EHDS) Multi-Stakeholder Statement
Launch of the PEARLDIVER Platform Trial for drug development and repurposing in Major Depressive Disorder
European Commission launches new “Biotech and Biomanufacturing Hub” to support innovative companies
New depression trial will use EU-PEARL study designs
EMA Offers Fee Waivers for Scientific Advice to Support Public Health Research
Concluding the Journey of the EATRIS-GSK Imaging Hub
Anton Ussi Confirmed as EATRIS Operations & Finance Director for a Further Five Years
Launch of New Handbook for ATMP Developers
